<DOC>
	<DOCNO>NCT02171052</DOCNO>
	<brief_summary>To investigate bioavailability dabigatran without concomitant administration digoxin bioavailability digoxin without concomitant administration dabigatran etexilate</brief_summary>
	<brief_title>Relative Bioavailability Dabigatran Digoxin Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Digoxin</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<criteria>1 . Healthy male female accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( BP , PR ) , 12lead ECG , clinical laboratory test 2 . Age ≥18 ≤65 year 3 . BMI ≥18.5 BMI ≤29.9 kg/m2 ( Body Mass Index ) 4 . Signed date write informed consent prior admission study accordance GCP local legislation . 1 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 2 . Relevant surgery gastrointestinal tract 3 . History bleed disorder acute blood coagulation defect 4 . Puls 50 bpm screen 5 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 6 . History relevant orthostatic hypotension , faint spell blackouts 7 . Chronic relevant acute infection 8 . History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator 9 . Intake medication within four week first dose . 10 . Use drug might reasonably influence result trial base knowledge time protocol preparation within four week prior administration trial 11 . Participation another trial investigational drug within two month prior administration trial 12 . Alcohol abuse ( 60 g/day ) 13 . Drug abuse 14 . Within 5 day study medication intake grapefruit , grapefruit juice , product contain grapefruit juice , Seville oranges , garlic supplement , St. John 's Worth 15 . Blood donation ( 100 mL within four week prior administration trial ) 16 . Excessive physical activity ( within one week prior administration trial ) 17 . Any laboratory value outside reference range clinical relevance 18 . Inability comply dietary regimen study centre 19 . Females child bear potential pregnant , breast feeding either surgically sterile sexually active use acceptable form contraception either oral contraceptive since least two month double barrier method , i.e . intrauterine device spermicide condom male partner 20 . Male subject must agree minimise risk female partner become pregnant first dose day 3 month completion post study medical . Acceptable method contraception comprise barrier contraception medically accept contraceptive method female partner ( intrauterine device spermicide , hormonal contraceptive since least two month ) 21 . Planned surgery within four week follow endof study examination 22 . Intake medication , influence blood clotting , i.e. , acetylsalicylic acid , cumarin etc . 23 . The subject able understand comply protocol requirement , instruction protocolstated restriction 24 . Vulnerable subject ( e.g . person keep detention ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>